Versacloz Suspension
Product Images NDC 52817-601
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Versacloz (NDC 52817-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-02 Cumulative (Figure 02 Cumulative)
Patient-use-instruction (Patient Use Instruction)
Figure-a-step-1 (Figure A Step 1)
Figure-b-step-2 (Figure B Step 2)
Figure-c-step-3 (Figure C Step 3)
Step-4 (Step 4)
Figure-d (Figure D)
Figure-e-step-5 (Figure E Step 5)
Figure-f-step-6 (Figure F Step 6)
Figure-g-step-7 (Figure G Step 7)
Figure-h-step-8 (Figure H Step 8)
Figure-i-step-9 (Figure I Step 9)
Figure-j-step-10 (Figure J Step 10)
Figure-k-step-11 (Figure K Step 11)
Figure-l-step-12 (Figure L Step 12)
Figure-m-step-13 (Figure M Step 13)
Figure-n-step-14 (Figure N Step 14)
Container Label (312371 Label Versacloz Oral Ssp 50 mg mL 100 mL Us Rev 06.2025)
Carton Label (312370 Ctn Versacloz Oral Ssp 50 mg mL 100 mL Us Rev 06.2025)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.